Loading...
Jupiter Neurosciences, Inc.
JUNS•NASDAQ
Healthcare
Biotechnology
$1.02
$-0.03(-2.86%)
Jupiter Neurosciences, Inc. (JUNS) Financial Performance & Statements
Review Jupiter Neurosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
20.14%
↑ 20.14%
Net Income Growth
49.001%
↑ 49.001%
Operating Cash Flow Growth
-713.18%
↓ 713.18%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
344.69%
↑ 344.69%
ROIC
-131.69%
↓ 131.69%
Jupiter Neurosciences, Inc. (JUNS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Jupiter Neurosciences, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $466745.00 | $201005.00 | $91911.00 | $101077.00 |
| SG&A Expenses | $1.07M | $1.26M | $401636.00 | $456000.00 |
| Operating Expenses | $1.54M | $1.46M | $493547.00 | $557077.00 |
| Total Costs & Expenses | $0.00 | $1.46M | $493547.00 | $557077.00 |
| Interest Income | $10365.00 | $5419.00 | $23.00 | $53.00 |
| Interest Expense | -$1229.00 | $30545.00 | $107382.00 | $56290.00 |
| Depreciation & Amortization | $0.00 | -$938749.00 | $9908.00 | $926490.00 |
| EBITDA | -$1.54M | -$1.50M | -$483639.00 | $369413.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$1.54M | -$1.46M | -$493547.00 | -$557077.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $9136.00 | -$69271.00 | -$97474.00 | $870200.00 |
| Income Before Tax | -$1.53M | -$1.53M | -$591021.00 | $313123.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.53M | -$1.53M | -$591021.00 | $313123.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.05 | -$0.05 | -$0.02 | $0.009 |
| Diluted EPS | -$0.05 | -$0.05 | -$0.02 | $0.009 |
| Weighted Avg Shares Outstanding | $33.10M | $28.78M | $31.07M | $32.88M |
| Weighted Avg Shares Outstanding (Diluted) | $33.10M | $28.78M | $31.07M | $32.88M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan